The natural history of children with severe combined immunodeficiency: Baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901

Journal of Clinical Immunology

Volumn 33, Issue 7, 2013, Pages 1156-1164

  Dvorak, Christopher C ^a   Cowan, Morton J ^a   Logan, Brent R ^b   Notarangelo, Luigi D ^c   Griffith, Linda M ^d   Puck, Jennifer M ^a   Kohn, Donald B ^e   Shearer, William T ^f   O'Reilly, Richard J ^g   Fleisher, Thomas A ^d   Pai, Sung Yun ^h   Hanson, I Celine ^f   Pulsipher, Michael A ⁱ   Fuleihan, Ramsay ^j   Filipovich, Alexandra ^k   Goldman, Frederick ^l   Kapoor, Neena ^m   Small, Trudy ^g   Smith, Angela ⁿ   Chan, Ka Wah ^o   Cuvelier, Geoff ^p   Heimall, Jennifer ^q   Knutsen, Alan ^r   Loechelt, Brett ^s   Moore, Theodore ^e   Buckley, Rebecca H ^t   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

^k CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^l UNIVERSITY OF ALABAMA   (United States)

^m CHILDREN S HOSPITAL LOS ANGELES   (United States)

ⁿ UNIVERSITY OF MINNESOTA   (United States)

^o TEXAS TRANSPLANT INSTITUTE   (United States)

^p UNIVERSITY OF MANITOBA   (Canada)

^q CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^r SAINT LOUIS UNIVERSITY   (United States)

^s CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^t DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

hematopoietic cell transplantation; newborn screening; Severe combined immunodeficiency

Indexed keywords

CALCINEURIN INHIBITOR; INTERLEUKIN 2 RECEPTOR GAMMA;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL ARTICLE; ENZYME REPLACEMENT; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; GENE THERAPY; GENETIC ANALYSIS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IL2RG GENE; IMMUNOPHENOTYPING; INFANT; MALE; NEWBORN SCREENING; NONMYELOABLATIVE CONDITIONING; OPPORTUNISTIC INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; SEVERE COMBINED IMMUNODEFICIENCY; T CELL DEPLETION;

BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENETIC TESTING; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; SEVERE COMBINED IMMUNODEFICIENCY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84885189606     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9917-y     Document Type: Article

References (31)

1. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 2004;22:625-55.
2. Notarangelo L. Primary immunodeficiencies. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S182-94.
3. Al-Herz W, Bousfiha A, Casanova J, Chapel H, Conley M, Cunningham-Rundles C et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2(54).
4. Parvaneh N, Casanova J, Notarangelo L, Conley M. Primary immunodeficiencies: A rapidly evolving story. J Allergy Clin Immunol. 2013;131(2):314-23.
5. Puck J. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: The winner is T-cell receptor excision circles. J Allergy Clin Immunol. 2012;129(3):607-16.
6. Buckley R. The long quest for neonatal screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2012;129(3):597-604.
7. Railey M, Lokhnygina Y, Buckley R. Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis. J Pediatr. 2009;155(6):834-40.
8. Gaspar H, Aiuti A, Porta F, Candotti F, Hershfield M, Notarangelo L. How I treat ADA deficiency. Blood. 2009;114(17):3524-32.
9. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Gene therapy for primary adaptive immune deficiencies. J Allergy Clin Immunol. 2011;127(6):1356-9.
10. Fernandes J, Rocha V, Labopin M, Neven B, Moshous D, Gennery A, et al. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Blood. 2012;119(12):2949-55.
11. Bertrand Y, Landais P, Friedrich W, Gerritsen B, Morgan G, Fasth A, et al. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency. J Pediatr. 1999;134(6):740-8.
12. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood. 2002;99(3):872-8.
13. Gennery A, Slatter M, Grandin L, Taupin P, Cant A, Veys P, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126(3):602-10. e1-11.
14. Dvorak C, Cowan M. Radiosensitive severe combined immunodeficiency disease. Immunol Allergy Clin N Am. 2010;30(1):125-42.
15. Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, et al. Long-term outcome after haematopoietic stem cell transplantation of a single-centre cohort of 90 patients with severe combined immunodeficiency: Long-term outcome of HSCT in SCID. Blood. 2009;113(7):4114-24.
16. Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340(7):508-16.
17. Dvorak C, Hung G, Horn B, Dunn E, Oon C, Cowan M. Megadose CD34(+) cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation. Biol Blood Marrow Transplant. 2008;14(10):1125-33.
18. Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295(5):508-18.
19. Haddad E, Le Deist F, Aucouturier P, Cavazzana-Calvo M, Blanche S, De Saint Basile G, et al. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients. Blood. 1999;94(8):2923-30.
20. Mazzolari E, Forino C, Guerci S, LA Imberti L, Porta F, Notarangelo LD. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol. 2007;120(4):892-9.
21. Buckley R. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol Res. 2011;49(1-3):25-43.
22. Buckley R, Win C, Moser B, Parrott R, Sajaroff E, Sarzotti-Kelsoe M. Post-Transplantation B Cell Function in Different Molecular Types of SCID. J Clin Immunol. 2013;33:96-110.
23. Patel N, Chinen J, Rosenblatt H, Hanson I, Krance R, Paul M, et al. Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning. J Allergy Clin Immunol. 2009;124(5):1062-9. e1-4.
24. Sarzotti-Kelsoe M, Win C, Parrott R, Cooney M, Moser B, Roberts J, et al. Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras. Blood. 2009;114(7):1445-53.
25. Lebet T, Chiles R, Hsu A, Mansfield E, Warrington J, Puck J. Mutations causing severe combined immunodeficiency: detection with a custom resequencing microarray. Genet Med. 2008;10(8):575-85.
26. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15(12):1628-33.
27. Cole C, Freitas A, Clifton M, Durham M. Hereditary multiple intestinal atresias: 2 new cases and review of the literature. J Pediatr Surg. 2010;45(4):E21-4.
28. Antoine C, Müller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003;361(9357):553-60.
29. Felgentreff K, Perez-Becker R, Speckmann C, Schwarz K, Kalwak K, Markelj G, et al. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol. 2011;141(1):73-82.
30. van der Burg M, Gennery A. The expanding clinical and immunological spectrum of severe combined immunodeficiency. Eur J Pediatr. 2011;170(5):561-71.
31. Titman P, Pink E, Skucek E, O'Hanlon KCT, Gaspar J, Xu-Bayford J, et al. Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies. Blood. 2008;112(9):3907-13.